Zhejiang Xianju Pharmaceutical Co Ltd (002332) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥130.05 Million ≈ $19.03 Million USD) by net assets (CN¥6.03 Billion ≈ $881.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Xianju Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Zhejiang Xianju Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Zhejiang Xianju Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
Zhejiang Xianju Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Xianju Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Electro Optic Systems Holdings Ltd
AU:EOS
|
-0.063x |
|
American Assets Trust Inc
NYSE:AAT
|
0.036x |
|
Cairn Homes PLC
IR:C5H
|
-0.020x |
|
Wacker Neuson SE
F:WAC
|
0.041x |
|
Jiangxi Hungpai New Material Co Ltd
SHG:605366
|
0.021x |
|
Guizhou Qianyuan Power Co Ltd
SHE:002039
|
0.125x |
|
Guangdong Sky Dragon Printing Ink Group Co Ltd
SHE:300063
|
0.063x |
|
Huaku Development Co Ltd
TW:2548
|
0.539x |
Annual Cash Flow Conversion Efficiency for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 002332 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.89 Billion ≈ $861.62 Million |
CN¥398.66 Million ≈ $58.34 Million |
0.068x | -33.71% |
| 2023-12-31 | CN¥5.83 Billion ≈ $853.12 Million |
CN¥595.48 Million ≈ $87.14 Million |
0.102x | -7.67% |
| 2022-12-31 | CN¥5.51 Billion ≈ $805.91 Million |
CN¥609.28 Million ≈ $89.16 Million |
0.111x | -19.09% |
| 2021-12-31 | CN¥4.94 Billion ≈ $723.59 Million |
CN¥676.15 Million ≈ $98.94 Million |
0.137x | -20.61% |
| 2020-12-31 | CN¥4.58 Billion ≈ $670.54 Million |
CN¥789.23 Million ≈ $115.49 Million |
0.172x | +1.34% |
| 2019-12-31 | CN¥3.06 Billion ≈ $447.57 Million |
CN¥519.81 Million ≈ $76.06 Million |
0.170x | +138.33% |
| 2018-12-31 | CN¥2.71 Billion ≈ $396.60 Million |
CN¥193.27 Million ≈ $28.28 Million |
0.071x | +1.60% |
| 2017-12-31 | CN¥2.39 Billion ≈ $349.14 Million |
CN¥167.47 Million ≈ $24.51 Million |
0.070x | +0.71% |
| 2016-12-31 | CN¥2.24 Billion ≈ $327.35 Million |
CN¥155.91 Million ≈ $22.81 Million |
0.070x | -24.84% |
| 2015-12-31 | CN¥2.15 Billion ≈ $314.98 Million |
CN¥199.61 Million ≈ $29.21 Million |
0.093x | -19.61% |
| 2014-12-31 | CN¥1.23 Billion ≈ $179.69 Million |
CN¥141.64 Million ≈ $20.73 Million |
0.115x | +114.84% |
| 2013-12-31 | CN¥1.18 Billion ≈ $172.97 Million |
CN¥63.46 Million ≈ $9.29 Million |
0.054x | +93.15% |
| 2012-12-31 | CN¥1.20 Billion ≈ $175.98 Million |
CN¥33.43 Million ≈ $4.89 Million |
0.028x | -78.28% |
| 2011-12-31 | CN¥1.15 Billion ≈ $168.80 Million |
CN¥147.63 Million ≈ $21.60 Million |
0.128x | -7.59% |
| 2010-12-31 | CN¥1.12 Billion ≈ $164.09 Million |
CN¥155.29 Million ≈ $22.72 Million |
0.138x | +45.55% |
| 2009-12-31 | CN¥1.10 Billion ≈ $160.99 Million |
CN¥104.68 Million ≈ $15.32 Million |
0.095x | +7.10% |
| 2008-12-31 | CN¥405.55 Million ≈ $59.34 Million |
CN¥36.03 Million ≈ $5.27 Million |
0.089x | -63.11% |
| 2007-12-31 | CN¥400.83 Million ≈ $58.65 Million |
CN¥96.53 Million ≈ $14.13 Million |
0.241x | +77.49% |
| 2006-12-31 | CN¥390.97 Million ≈ $57.21 Million |
CN¥53.05 Million ≈ $7.76 Million |
0.136x | -- |
About Zhejiang Xianju Pharmaceutical Co Ltd
Zhejiang Xianju Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progestero… Read more